TÜRKÇE
ENGLISH
Information
| Code | ECF303 |
| Name | Pharmaceutical Chemistry II |
| Term | 2024-2025 Academic Year |
| Semester | 5. Semester |
| Duration (T+A) | 2-0 (T-A) (17 Week) |
| ECTS | 4 ECTS |
| National Credit | 2 National Credit |
| Teaching Language | Türkçe |
| Level | Lisans Dersi |
| Type | Normal |
| Mode of study | Yüz Yüze Öğretim |
| Catalog Information Coordinator | Dr. Öğr. Üyesi ÖZDEN TARI |
| Course Instructor |
Dr. Öğr. Üyesi ÖZDEN TARI
(A Group)
(Ins. in Charge)
|
Course Goal / Objective
The purpose of this course is to understanding of a basic concept on general features, mode of action, structure-activity relationship, synthesis and biotransformation of the drugs affecting on autonomic nerveous system and cardiovascular system.
Course Content
Adrenergic agents, adrenergic blocking agents, cholinergic agents, cholinergic blocking agents, cardiac glycosides, antiarrhythmics, antianginal and vasodilatory agents, antihypertensives, antihyperlipidemics, coagulant and anticoagulant agents, antianemic drugs, trombolytics, antiaggregan agents and diuretics.
Course Precondition
None
Resources
H. Akgün, A. Balkan, A. A. Bilgin, Ü. Çalış ve ark. Farmasötik Kimya Kitabı, Hacettepe Üniversitesi Yayınları, 2013.
Notes
H. Akgün, A. Balkan, A. A. Bilgin, Ü. Çalış ve ark. Farmasötik Kimya Kitabı, Hacettepe Üniversitesi Yayınları, 2013.
Course Learning Outcomes
| Order | Course Learning Outcomes |
|---|---|
| LO01 | The student who completes this course describes the autonomic nerveous system drugs; analeptic, adrenergic, adrenergic blocking, cholinergic, cholinergic blocking agents. |
| LO02 | The student who completes this course explains basic concept on general features, mode of action, structure-activity relationship, synthesis of autonomic nerveous system drugs. |
| LO03 | The student who completes this course explains biotransformation of autonomic nerveous system drugs. |
| LO04 | The student who completes this course explains cardiovascular system drugs. |
| LO05 | The student who completes this course explains mode of action, structure-activity relationship, synthesis and biotransformation of cardiovascular system drug. |
Relation with Program Learning Outcome
| Order | Type | Program Learning Outcomes | Level |
|---|---|---|---|
| PLO01 | Bilgi - Kuramsal, Olgusal | Have sufficient knowledge in pharmaceutical field and develop the knowledge. | 5 |
| PLO02 | Bilgi - Kuramsal, Olgusal | Comprehends professional knowledge with ethical responsibility through current laws and legislation. | 1 |
| PLO03 | Beceriler - Bilişsel, Uygulamalı | Provides consultancy service to patients, community and health care personnel and evaluates advanced knowledge and skills with a critical approach. | 5 |
| PLO04 | Beceriler - Bilişsel, Uygulamalı | Possessing the knowledge of historical and current developments in the field of Pharmacy, monitoring, evaluation and application of scientific and evidence-based data, and adopting lifelong learning. | 3 |
| PLO05 | Beceriler - Bilişsel, Uygulamalı | Have the knowledge and skills to help provide patient-oriented pharmacy applications and individualized pharmaceutical care by learning the basics of Clinical Pharmacy, | 3 |
| PLO06 | Yetkinlikler - Bağımsız Çalışabilme ve Sorumluluk Alabilme Yetkinliği | Takes a role in the evaluation and analysis of the events and cases related to the development of pharmacy profession and education. | 3 |
| PLO07 | Yetkinlikler - Öğrenme Yetkinliği | Integrates and develops professional knowledge via different disciplines and uses the acquired knowledge to improve the health level and quality of life of the community. | 4 |
| PLO08 | Yetkinlikler - Öğrenme Yetkinliği | Use effectively the concepts and applications of basic sciences and basic medical sciences in the field of medicine and pharmacy and update the information. | 3 |
| PLO09 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Communicates effectively in writing and speaking. | 3 |
| PLO10 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Practices the profession in accordance with Atatürk's principles and reforms, equipped with universal knowledge, uses Turkish correctly and knows at least one foreign language. | |
| PLO11 | Yetkinlikler - İletişim ve Sosyal Yetkinlik | Be an example to society withexternal appearance, demeanor, attitude and behavior for the other professionals and society and with professional identity | |
| PLO12 | Yetkinlikler - Alana Özgü Yetkinlik | Have knowledge about health policies and health economics, pharmacy management and define the problems in pharmaceutical field. | 1 |
| PLO13 | Yetkinlikler - Alana Özgü Yetkinlik | Interprets information about current health and treatment problems and attends meeting on related matters . Plays an active role in community health. | 3 |
| PLO14 | Yetkinlikler - Alana Özgü Yetkinlik | Acquires basic information about diseases, makes decisions about the drugs used in treatment in accordance with rational drug use. | 5 |
Week Plan
| Week | Topic | Preparation | Methods |
|---|---|---|---|
| 1 | Analeptic and adrenergic drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 2 | Adrenergic blockers | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 3 | Cholinergic drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 4 | Cholinergic blockers | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 5 | Cardiovascular drugs, drug for the treatment of congestive heart filure | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 6 | Antiarrhytmicdrugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 7 | Antianginal drugs, periferic vasodilator drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 8 | Mid-Term Exam | Repetition of lecture notes | Ölçme Yöntemleri: Yazılı Sınav |
| 9 | Antihypertensive drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 10 | Diuretic drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 11 | Electrolytes and acide-base regulators | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 12 | Antihyperlipidemic drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 13 | Hemostatic and anticoagulant drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 14 | Antitrobocyte and trombolytic drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 15 | Antianemic drugs | Reading the relevant lecture note | Öğretim Yöntemleri: Anlatım, Soru-Cevap, Tartışma |
| 16 | Term Exams | Repetition of lecture notes | Ölçme Yöntemleri: Yazılı Sınav |
| 17 | Term Exams | Repetition of lecture notes | Ölçme Yöntemleri: Yazılı Sınav |
Student Workload - ECTS
| Works | Number | Time (Hour) | Workload (Hour) |
|---|---|---|---|
| Course Related Works | |||
| Class Time (Exam weeks are excluded) | 14 | 2 | 28 |
| Out of Class Study (Preliminary Work, Practice) | 14 | 2 | 28 |
| Assesment Related Works | |||
| Homeworks, Projects, Others | 1 | 0 | 0 |
| Mid-term Exams (Written, Oral, etc.) | 1 | 8 | 8 |
| Final Exam | 1 | 24 | 24 |
| Total Workload (Hour) | 88 | ||
| Total Workload / 25 (h) | 3,52 | ||
| ECTS | 4 ECTS | ||